1. McCormick M H, Stark WM, Pittinger GE, Pittinger RC, Mcguire JM. Vancomycin, a new antibiotic. 1 Chemical and biological properties. In: Welch H, Marti-Ibanez F, Eds., Antibiotics Annual 1955-1956, New York, USA Medical Encyclopaedia Inc., 1956: 606–11.
2. Felmingham D. Glycopeptides. In: O’Grady F, Lambert HP, Finch RG. Greenwood D, Eds. Antibiotic and Chemotherapy. New York, USA: Churchill Livingstone Inc. 1997: 363–70.
3. Wilson APR, Grüneberg RN. Chemistry, mode of action and antibacterial activity. In: Teicoplanin: The first decade. Abingdon, UK: The Medicine Group (Educational) Ltd. 1997: 11–30.
4. NCCLS. Performance standards for antimicrobial susceptibility testing-Ninth informational supplement. NCCL document M100-S9. NCCLS, Wayne, Pennsylvania, USA, 1999.
5. Felmingham D. Glycopeptides: vancomycin and teicoplanin. In: Reeves DS, Wise R, Andrews JM, White LO, Eds, Clinical Antimicrobial Assays, Oxford, UK: Oxford University Press, 1999: 137–48.